2% xylocaine dental with adrenaline (epinephrine) 1:80,000
dentsply sirona (nz) limited - adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline; ; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - the product is indicated for the production of local nerve anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.
xylocaine 2.0% 400mg/20ml injection ampoule
aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; dilute hydrochloric acid - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.
xylocaine 2.0% 100mg/5ml injection ampoule
aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.
xylocaine 1% (200mg/20ml) injection ampoule
aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; dilute hydrochloric acid - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.
xylocaine 1% (50mg/5ml) ampoule
aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.
xylocaine 2.0% 40mg/2ml injection ampoule
aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block
xylocaine 1% (20mg/2ml) ampoule
aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block
2% nurocain dental with adrenaline 1:100,000 2.2ml injection cartridge
dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 17 july 2003 : lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.
xylocaine 1% with adrenaline 1:100,000
pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; ; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment nitrogen as nitrogen for injection sodium chloride sodium hydroxide as 2m solution for ph adjustment sodium metabisulfite water for injection
xylocaine 2% with adrenaline 1:80,000
astrazeneca limited - adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline; lidocaine hydrochloride 20 mg/ml; ; - solution for injection - active: adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection